Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2013 - 2026)
Eledon Pharmaceuticals (ELDN) reported Other Accumulated Expenses of $55000.0 for Q1 2026, down 31.25% on a YoY basis from $80000.0 in Q1 2025, and down 91.3% quarter-over-quarter from $632000.0 in Q4 2025.
Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals has reported Other Accumulated Expenses for 14 years, with the latest figure at $55000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses fell 31.25% year-over-year to $55000.0; the trailing twelve-month figure through Mar 2026 stood at $55000.0 (down 31.25% YoY), and the FY2025 full-year result was $632000.0, up 1244.68% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $55000.0, down from $632000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $705000.0 in Q2 2024, with the low at $13000.0 in Q2 2022.
- Historically, Other Accumulated Expenses has averaged $127176.5 across 5 years, with a median of $50000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 1755.26% — and 2025, when it sank 95.89%.
- Eledon Pharmaceuticals' Other Accumulated Expenses stood at $112000.0 in 2022, then plunged by 60.71% to $44000.0 in 2023, then grew by 6.82% to $47000.0 in 2024, then jumped by 1244.68% to $632000.0 in 2025, then sank by 91.3% to $55000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $55000.0 (Q1 2026), $632000.0 (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Eledon Pharmaceuticals | 401.35 Mn | 185.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | 39,000.00 |
| Jun 30, 2021 | 17,000.00 |